Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and twenty-one have given a buy rating […]
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and twenty-one have given a buy rating […]
